Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  idarubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 153 for your search:
Start Over
Treatment of Acute Myeloblastic Leukemia in Younger Patients
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 0 to 75
Sponsor: Other
Protocol IDs: LPA 2005, NCT00408278
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: Pethema LPA-99 protocol, NCT00465933
LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: AML-01.10, NCT01587430
Phase II/III Randomized Study of Monoclonal Antibody HuM195 As Maintenance Therapy in Elderly Patients with Acute Myeloid Leukemia in Complete Remission Following Chemotherapy (Summary Last Modified 12/98)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: MYFLAI07, NCT00909168
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 80
Sponsor: Other
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816
Combination Chemotherapy in Treating Patients With Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835
Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16-60
Sponsor: Other
Protocol IDs: CDR0000065336, EORTC-06961, NCT00002926
Start Over